Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
1.950
-0.090 (-4.41%)
Aug 15, 2025, 10:02 AM - Market open

Aptevo Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-24.03-24.13-17.418.03-28.46-17.75
Upgrade
Depreciation & Amortization
0.270.350.570.91.141.31
Upgrade
Loss (Gain) From Sale of Assets
---0.050-
Upgrade
Stock-Based Compensation
0.091.072.191.81.641.26
Upgrade
Other Operating Activities
--0.01-33.946.642.52
Upgrade
Change in Accounts Receivable
--2.51.16-1.3-2.37
Upgrade
Change in Accounts Payable
-0.53-1.020.52-0.39-1.92-0.7
Upgrade
Change in Other Net Operating Assets
-0.46-0.06-0.111.370.560.67
Upgrade
Operating Cash Flow
-24.65-23.79-11.73-21.02-21.68-29.32
Upgrade
Capital Expenditures
----0.03-0.71-0.09
Upgrade
Other Investing Activities
-----28.12
Upgrade
Investing Cash Flow
----0.03-0.7128.03
Upgrade
Long-Term Debt Issued
-----24.73
Upgrade
Long-Term Debt Repaid
---3.47-12.27-10.55-22.1
Upgrade
Net Debt Issued (Repaid)
---3.47-12.27-10.552.63
Upgrade
Issuance of Common Stock
25.9915.69.486.9311.4421.26
Upgrade
Repurchase of Common Stock
--0-0.01-0--0.01
Upgrade
Other Financing Activities
--0-2.7225.27-
Upgrade
Financing Cash Flow
25.9915.66-2.6226.1623.87
Upgrade
Net Cash Flow
1.34-8.19-5.73-23.673.7722.59
Upgrade
Free Cash Flow
-24.65-23.79-11.73-21.05-22.39-29.41
Upgrade
Free Cash Flow Margin
----676.01%-182.17%-682.43%
Upgrade
Free Cash Flow Per Share
-113.66-1722.68----
Upgrade
Levered Free Cash Flow
-14.82-15.52-11.7-29.322.01-13.29
Upgrade
Unlevered Free Cash Flow
-14.82-15.52-11.7-29.322.01-13.29
Upgrade
Change in Working Capital
-0.98-1.082.912.14-2.66-2.41
Upgrade
Updated Aug 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q